Why Moderna Stock Is Rocketing Higher Today
Mid-cap biotech Moderna (NASDAQ: MRNA) is on the move again today. Shares are up by a noteworthy 11.7% as of 10:23 a.m. EST Tuesday.
Moderna's shares are jumping in response to news that the company's experimental mRNA COVID-19 vaccine, mRNA-1273, has been shipped to U.S. governmental researchers at the National Institute of Allergy and Infectious Diseases. The company expects the vaccine's first clinical trial to kick off in April. The initial results from this early-stage trial should be available by August.
Image source: Getty Images.
Source Fool.com
